1. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Heidenreich;Circulation,2022
2. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials;Vaduganathan;Lancet,2020
3. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial;Mebazaa;Lancet,2022
4. Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: a multinational observational study (EVOLUTION HF);Savarese;JACC Heart Fail,2023
5. Heart failure pharmacological management: gaps and current perspectives;Severino;J Clin Med,2023